Lufotrelvir (PF-07304814) is a phosphate prodrug of PF-00835231 which acts as a 3CLpro protease (Mpro) inhibitor with anti-SARS-CoV-2 activity. It is being developed by Pfizer As an antiviral drug. As a prodrug, Lufotrelvir has to be metabolized (with the phosphate group being cleaved) in vivo to yield the active agent PF-00835231.

纯度：≥98%

CAS：2468015-78-1